Evaluation of serum ischemia-modified albumin levels in high-normal blood pressure category

对高血压正常人群血清缺血修饰白蛋白水平的评估

阅读:1

Abstract

BACKGROUND: High-normal blood pressure (BP), situated inside the elevated normal range and indicative of potential hypertension, is widely acknowledged as a critical worldwide health issue. High-normal BP levels consist of a systolic measurement of 130-139 mmHg and a diastolic measurement of 85-89 mmHg. Ischemia-modified albumin (IMA) is a sign that tissues are not getting enough oxygen, which is also known as tissue hypoxia. Numerous studies indicate that IMA possesses prognostic relevance in cardiovascular diseases. Our purpose was to investigate the serum IMA levels in patients with high-normal BP. MATERIALS AND METHODS: The study prospectively enrolled 50 participants with high-normal BP and 50 individuals with normal BP consecutively. Both groups' IMA levels were assessed and compared. All patients' echocardiograms were collected. RESULTS: The IMA values were markedly elevated in the high-normal group (P < 0.001). The research identified a significant correlation between IMA and high-normal BP, with an odds ratio of 1.725 (95% confidence interval [CI] 1.212-2.506, P < 0.001). An IMA level of 348 ng/L demonstrated a 94% accuracy in predicting high-normal BP, with a 32% accuracy overall (area under the curve = 0.942; 95% CI, 0.894-0.991; P < 0.001). CONCLUSION: Our analysis demonstrated a strong correlation between IMA and high-normal BP.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。